Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Osaterone enhances bone formation in ovariectomized rats

May 12, 1997

Effects of L-692429 in obese and nonobese young men

May 12, 1997

Procter & Gamble and Hoechst Marion Roussel to comarket Actonel

May 12, 1997

Prodrugs of calcitriol disclosed by Wisconsin Alumni Research Foundation

May 12, 1997

Selective beta3-agonists from Lilly

May 12, 1997

Lilly discloses selective beta3-agonists

May 9, 1997

Smith & Nephew to evaluate DynaGen's Orthodyn

May 9, 1997

Baxter files European marketing application for HemAssist

May 8, 1997

CSID enzyme replacement therapy submitted for approval

May 8, 1997

FDA decision on generic Premarin

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.